Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Soo

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Cardio-Oncology (London, England)|March 12, 2026
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosisOrly Leiva, Steven Soo, Olivia C Liu, et al.
Blood Advances|March 4, 2026
Low Serum Cholesterol Is a Biomarker of Advanced Disease and Poor Outcomes in Myeloproliferative NeoplasmsOrly Leiva, Steven Soo, Olivia C Liu, et al.
Blood Advances|January 7, 2026
Impact of Statin Use on Cardiovascular and Hematologic Outcomes Among Patients with Myeloproliferative NeoplasmsOrly Leiva, Steven Soo, Olivia C Liu, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Cardio-Oncology (London, England)|March 12, 2026
Echocardiographic high-output heart failure is associated with worse survival among patients with myelofibrosisOrly Leiva, Steven Soo, Olivia C Liu, et al.
Blood Advances|March 4, 2026
Low Serum Cholesterol Is a Biomarker of Advanced Disease and Poor Outcomes in Myeloproliferative NeoplasmsOrly Leiva, Steven Soo, Olivia C Liu, et al.
Blood Advances|January 7, 2026
Impact of Statin Use on Cardiovascular and Hematologic Outcomes Among Patients with Myeloproliferative NeoplasmsOrly Leiva, Steven Soo, Olivia C Liu, et al.
Pageof 2